abemaciclib with endocrine as frontline therapy
Published 5 years ago • 182 plays • Length 6:32Download video MP4
Download video MP3
Similar videos
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
4:31
fda d.i.s.c.o. burst edition: fda approval of verzenio (abemaciclib) with endocrine therapy for p...
-
8:55
abemaciclib with endocrine therapy in the treatment of high-risk early breast cancer: asco optima...
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
1:12
remaining questions on the use of frontline cdk4/6 inhibitors endocrine therapy
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
2:28
expert discusses promise of abemaciclib for breast cancer treatment
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
-
2:06
response to abemaciclib in the neomonarch trial
-
1:56
exploring extended adjuvant endocrine therapy for hr breast cancer
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
32:14
navigating between endocrine therapy, chemotherapy, and cdk 4/6 inhibitors for high-risk hr /her2...
-
6:21
nccn animation for patients: overview of endocrine therapy for metastatic breast cancer
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer